Subtraction Analysis of Trabecular Meshwork Genes
About the Research Project
Program
Award Type
Standard
Award Amount
$60,000
Active Dates
April 01, 2000 - March 31, 2002
Grant ID
G2000033
Summary
The trabecular meshwork (TM) is a network of drainage canals near the front of the eye through which the aqueous humor, or fluid inside the eyeball, drains. Defects in the TM, which lead to abnormally high intraocular pressure (IOP), are thought to be one of the factors that contribute to the development of glaucoma. Dr. Tamm has identified two genes that are turned on or off as tissue culture cells are induced to differentiate into TM cells. One of these genes (Pax-6) is a known genetic communicator essential for normal eye development. It is turned off as cells differentiate. Dr. Tamm is seeking to determine whether alterations in Pax-6 might cause impaired development of the TM and cause congenital glaucoma. The other gene, uteroglobin, is normally secreted in response to steroids and can form complexes with another protein called fibronectin. By forming these complexes, uteroglobin can prevent fibronectin from aggregating in a way that causes disease. Dr. Tamm has hypothesized that uteroglobin in the TM may help to prevent fibronectin from blocking aqueous outflow. This study is an extension of an NGR-funded project to identify genes involved in TM development and function and to determine the possible role of genes in the development of glaucoma.
Related Grants
National Glaucoma Research
Maldevelopment of Schlemm's Canal in Children with Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Revathi Balasubramanian, PhD
Current Organization
Columbia University
Maldevelopment of Schlemm's Canal in Children with Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Revathi Balasubramanian, PhD
Current Organization
Columbia University
National Glaucoma Research
Using Artificial Intelligence to Discover Genetic Risk Factors for Glaucoma Worsening
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Nazlee Zebardast, MD, MPH
Current Organization
Massachusetts Eye and Ear Infirmary
Using Artificial Intelligence to Discover Genetic Risk Factors for Glaucoma Worsening
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Nazlee Zebardast, MD, MPH
Current Organization
Massachusetts Eye and Ear Infirmary
National Glaucoma Research
Understanding Optic Nerve Head Astrocyte Contributions to Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Evan Cameron, PhD
Current Organization
Cleveland Clinic - Lerner Research Institute
Understanding Optic Nerve Head Astrocyte Contributions to Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Evan Cameron, PhD
Current Organization
Cleveland Clinic - Lerner Research Institute